生产企业：Pharmacosmos
Ferric derisomaltose is an iron injection used in the treatment of iron deficiency anemia.
Ferric derisomaltose is an iron injection used in the treatment of iron deficiency anemia.
This drug is a complex made of iron (III) hydroxide and derisomaltose, which is an iron carbohydrate oligosaccharide that works to releases iron. The released iron then binds to the transport protein, transferrin, and is taken to erythroid precursor cells for incorporation into the hemoglobin molecule.
This drug is indicated for the treatment of iron deficiency anemia in adult patients who have experienced intolerance to oral iron preparations or insufficient clinical response to orally administered iron. Ferric derisomaltase is also indicated for patients with non-hemodialysis dependent chronic kidney disease. In Australia and United Kingdom, ferric derisomaltase is indicated for cases in which rapid delivery of iron is required.
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
